Cronos (CRON) Total Current Liabilities (2016 - 2026)
Cronos' (CRON) quarterly Total Current Liabilities came in at $42.4 million in Q1 2026, up 28.36% year-on-year from $33.0 million in Q1 2025, and down 11.97% quarter-over-quarter from $48.2 million in Q4 2025.
Cronos (CRON) Total Current Liabilities (2016 - 2026) Analysis & Trends
Cronos' Total Current Liabilities history runs 11 years deep, the most recent figure standing at $42.4 million for Q1 2026.
- On a quarterly basis, Total Current Liabilities rose 28.36% year-over-year to $42.4 million in Q1 2026; TTM through Mar 2026 was $42.4 million, a 28.36% increase from a year earlier, with the FY2025 full-year figure at $48.2 million, down 3.04% from the prior year.
- Total Current Liabilities eased to $42.4 million in Q1 2026 per CRON's latest filing, from $48.2 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $49.7 million in Q4 2024 and bottomed at $5.6 million in Q4 2022.
- The 5-year median for Total Current Liabilities is $38.0 million (2022), against an average of $35.9 million.
- Across the five-year window, Total Current Liabilities slumped 86.7% in 2022 and surged 640.19% in 2023, its largest moves.
- Year by year, Total Current Liabilities stood at $5.6 million in 2022, then jumped by 640.19% to $41.4 million in 2023, then climbed by 20.05% to $49.7 million in 2024, then declined by 3.04% to $48.2 million in 2025, then slipped by 11.97% to $42.4 million in 2026.
- Per Business Quant, the three latest CRON Total Current Liabilities figures stand at $42.4 million (Q1 2026), $48.2 million (Q4 2025), and $41.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.56 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.53 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 18.06 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 599.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 6.81 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 831.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.66 Bn |
| 10 | Cronos | 1.04 Bn | 267.78 Mn | 19.15 Mn | 42.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42.42 Mn |
| Dec 31, 2025 | 48.19 Mn |
| Sep 30, 2025 | 41.07 Mn |
| Jun 30, 2025 | 37.61 Mn |
| Mar 31, 2025 | 33.05 Mn |
| Dec 31, 2024 | 49.70 Mn |
| Sep 30, 2024 | 39.56 Mn |
| Jun 30, 2024 | 33.06 Mn |
| Mar 31, 2024 | 33.42 Mn |
| Dec 31, 2023 | 41.40 Mn |
| Sep 30, 2023 | 30.58 Mn |
| Jun 30, 2023 | 27.93 Mn |
| Mar 31, 2023 | 29.13 Mn |
| Dec 31, 2022 | 5.59 Mn |
| Sep 30, 2022 | 37.97 Mn |
| Jun 30, 2022 | 39.20 Mn |
| Mar 31, 2022 | 40.25 Mn |
| Dec 31, 2021 | 13.46 Mn |
| Sep 30, 2021 | 69.60 Mn |
| Jun 30, 2021 | 200.60 Mn |